Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial-Reference-Cited by-同舟云学术

Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial

Published:2017-06 Issue: Volume:188 Page:147-155
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Abnousi Freddy,Sundaram Vandana,Yong Celina M.,Prats Jayne,Deliargyris Efthymios N.,Stone Gregg W.,Hamm Christian W.,Steg Philippe Gabriel,Gibson Charles Michael^ORCID,White Harvey D.,Price Matthew J.,Généreux Philippe,Desai Manisha,Yang Lingyao,Ding Victoria Y.,Harrington Robert A.,Bhatt Deepak L.,Mahaffey Kenneth W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials;Mehta;JAMA,2005

2. To cath or not to cath: that is no longer the question;Bhatt;JAMA,2005

3. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary

4. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara;J Am Coll Cardiol,2013

5. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation;Steg;Eur Heart J,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX;Clinical Cardiology;2019-06-29

2. Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use;Therapeutic Advances in Cardiovascular Disease;2019-01